Nutrient | Study name | Location | Recruitment status | Identifier |
---|---|---|---|---|
Vitamin D | The VITALITY trial | Australia | Recruiting | NCT02112734 |
Vitamin A | Vitamin A supplementation at birth and atopy in childhood | Guinea Bissau | Active | NCT01779180 |
PUFAs | DHA to Optimise Mother Infant Outcomes (DOMInO) trial | Australia | Completed | ACTRN12605000569606 |
PUFAs | The Infant Fish Oil Supplementation (IFOS) trial | Australia | Active | ACTRN12606000281594 |
PUFAs | Can supplementation with Lactobacillus reuteri and omega-3 fatty acids during pregnancy and lactation reduce the risk of allergic disease in infancy? (PROOM-3)* | Sweden | Recruiting | NCT01542970 |
Probiotics | Primary prevention of atopic disease by perinatal administration of probiotics | The Netherlands | Completed | NCT00200954 |
Probiotics | Influence of probiotics on atopy, immunological responses and gut microflora, follow-up to 5 years | Singapore | Completed | NCT00365469 |
Probiotics | Microbiota as a potential target for food allergy | Italy | Recruiting | NCT02087930 |
Probiotics | Effect of lactobacillus GG on atopic march | Italy | Recruiting | NCT01891916 |
Prebiotic | Prebiotics in the Prevention of Atopy (PIPA) | Italy | Completed | NCT02116452 |
†Atopic sensitisation.
PUFA, polyunsaturated fatty acid.